Cardiac AI: Proving ROI in Value-Based Care
The Imperative of Outcomes Data in Value-Based AI The core tenet of value-based care is simple: pay for health outcomes, not just services rendered. This…
The Imperative of Outcomes Data in Value-Based AI The core tenet of value-based care is simple: pay for health outcomes, not just services rendered. This…
For self-insured employers and payers, the financial return on digital health investments hinges on preventing high-cost cardiovascular events before they occur. The transition to value-based…
The field of healthcare investment is undergoing a seismic shift, driven by the Centers for Medicare & Medicaid Services (CMS) relentless push towards value-based care.…
The pervasive burden of cardiovascular disease (CVD) on global healthcare systems demands innovative solutions, yet investors are increasingly scrutinizing AI health platforms for tangible, quantifiable…
The relentless financial burden of avoidable cardiac emergency room visits and subsequent hospitalizations represents a critical pain point in the US healthcare system, draining billions…
The persistent challenge of healthcare economics is stark: a mere 5 percent of patients account for nearly 50 percent of total healthcare spending. These high-need,…
The Medicare Advantage Value-Based Insurance Design (VBID) model, which allowed payers to tailor benefits to chronic disease patients, was intended to drive down costs and…
The proliferation of AI-driven clinical decision support (CDS) tools promises far-reaching efficiency and improved outcomes. Yet, a critical trust gap persists among risk-bearing providers, investors,…
Managing chronic kidney disease (CKD) represents one of healthcare’s most significant financial burdens, with late-stage CKD and End-Stage Renal Disease (ESRD) costs soaring into the…
The promise of digital diabetes management solutions has long captivated investors and employers, offering a compelling vision of improved health outcomes alongside significant cost reductions.…